Earnings Ahead

NVAX - Novavax, Inc.

7.08 0.41 6.15

Novavax, Inc.

Novavax, Inc.

About

Profile

Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and adjuvant technology are the foundation for groundbreaking innovation that improves


Headquarters

Rockville, Maryland, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

NVAX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Novavax falls as Q4 results and 2024 outlook disappoint
  • SMXT, ANVS and IFBD among pre-market losers
  • Novavax GAAP EPS of -$1.44 misses by $0.99, revenue of $291M misses by $30.97M
  • ‘Tripledemic’ burden lower this winter despite COVID impact: Airfinity
  • Novavax Q4 2023 Earnings Preview
  • Novavax nears five-month high as COVID vaccine dispute ends
  • 5 stocks to watch on Thursday: Moderna, Enerplus on Chord Energy deal and more
  • Novavax settles COVID-19 vaccine dispute with Gavi
  • CDC to relax COVID isolation requirements: WaPo
  • Novavax-backed malaria vaccine shows 75% efficacy
  • Novavax to cut 12% of global workforce amid restructuring drive
  • Masking returns to some U.S. hospitals amid rising COVID, flu cases
  • Bank of America more favorable on SMID-cap biotechs into 2024
  • Novavax in 2024: What to expect?
  • JN.1 Omicron strain becomes dominant COVID variant in U.S.
  • Pfizer hits 52-week low, drags COVID vaccine peers on weak guidance
  • Canadian regulators authorize updated Novavax COVID-19 vaccine
  • Novavax settles class action lawsuit over COVID vaccine for $47M
  • Novavax's updated Covid-19 vaccine gets WHO emergency use listing
  • Pneumonia outbreak in China is no reason for alarm: WHO

Earnings History

Date EPS / Forecast Revenue / Forecast
November 4, 2021 -4.31 / -3.91 178.84M / 334.53M
August 5, 2021 -4.75 / -3.63 298.02M / 387.87M
May 10, 2021 -3.05 / -3.6 447.23M / 233.9M Beat!
March 1, 2021 -2.7 / -2.23 279.66M / 202.44M Beat!
November 9, 2020 -3.21 / 1.73 157.02M / 230.56M
August 10, 2020 -0.3 / -0.51 35.54M / 28.2M Beat!
May 11, 2020 -0.58 / -0.69 3.38M / 1.93M Beat!
March 11, 2020 -1.13 / -1.06 8.82M / 2.06M Beat!
November 7, 2019 -0.74 / -0.77 2.51M / 2.66M
August 7, 2019 -1.69 / -1.6 3.36M / 3.06M Beat!
May 2, 2019 -2.2 / -2.13 3.98M / 4.42M
Date Price Open High Low Vol Change ER
May 26, 2023 7.21 6.92
7.26
6.8
4.1M 4.64%
May 25, 2023 6.89 7.21
7.35
6.64
6.4M -5.49%
May 24, 2023 7.29 8.3
8.3
7.24
5.5M -8.76%
May 23, 2023 7.99 7.56
8.26
7.42
6.9M 5.97%
May 22, 2023 7.54 7.11
7.61
7.09
3.7M 5.45%
 
May 19, 2023 7.15 7.37
7.41
7.1
3.7M -3.64%
May 18, 2023 7.42 7.75
7.76
7.33
4.6M -4.26%
May 17, 2023 7.75 7.69
7.8
7.43
3.6M 1.44%
May 16, 2023 7.64 8.1
8.1
7.57
4.3M -5.8%
May 15, 2023 8.11 8.4
8.51
8.04
4.1M -4.02%
May 12, 2023 8.45 9.02
9.34
8.38
4.5M -4.95%
May 11, 2023 8.89 9
9.37
8.6
5.5M -1.11%
May 10, 2023 8.99 10.01
10.02
8.89
9.3M -5.57%
May 9, 2023 9.52 8.97
11.36
8.91
42.6M 27.79%
May 8, 2023 7.45 7.67
7.74
7.26
3.5M -3.37%
May 5, 2023 7.71 7.62
8.1
7.53
5.8M 1.85%
May 4, 2023 7.57 7.2
7.62
7.05
3.5M 5.87%
May 3, 2023 7.15 7.01
7.3
6.89
3.0M 1.56%
May 2, 2023 7.04 7.64
7.75
7.03
3.5M -8.81%
May 1, 2023 7.72 7.69
7.75
7.44
2.2M 0.65%
Apr 28, 2023 7.67 7.46
7.77
7.33
3.4M 1.46%
Apr 27, 2023 7.56 7.61
7.87
7.36
4.4M 0.40%
Apr 26, 2023 7.53 7.65
7.76
7.41
3.9M -1.31%
Apr 25, 2023 7.63 8.28
8.36
7.61
4.6M -5.57%
Apr 24, 2023 8.08 8.53
8.69
8.03
3.5M -6.91%
Apr 21, 2023 8.68 8.28
8.89
8.24
5.2M 5.47%
Apr 20, 2023 8.23 8.52
8.56
8.02
7.3M -8.15%
Apr 19, 2023 8.96 9.1
9.3
8.7
3.9M -3.66%
Apr 18, 2023 9.3 9.54
9.54
8.51
7.1M -1.69%
Apr 17, 2023 9.46 9.33
9.68
8.94
4.8M 3.28%
Apr 14, 2023 9.16 9.43
9.53
9.01
4.0M -3.78%
Apr 13, 2023 9.52 9.18
9.53
8.97
6.2M 5.31%
Apr 12, 2023 9.04 9.15
9.34
8.74
7.3M 0%
Apr 11, 2023 9.04 8.25
9.09
8.12
6.8M 13%
Apr 10, 2023 8 8.56
8.57
7.63
5.9M -5.44%
Apr 6, 2023 8.46 7.65
8.95
7.59
8.9M 11.46%
Apr 5, 2023 7.59 7.36
7.83
7.09
5.7M 3.41%
Apr 4, 2023 7.34 7.37
7.49
7.12
5.8M -0.81%
Apr 3, 2023 7.4 6.98
7.48
6.85
5.5M 6.78%
Mar 31, 2023 6.93 6.63
7.13
6.56
5.2M 5.16%
Mar 30, 2023 6.59 6.77
6.8
6.52
3.2M -1.05%
Mar 29, 2023 6.66 6.25
6.71
6.2
4.7M 8.12%
Mar 28, 2023 6.16 6.11
6.2
6.05
2.4M 1.15%
Mar 27, 2023 6.09 6.04
6.14
5.81
2.9M 0.83%
Mar 24, 2023 6.04 5.73
6.13
5.71
4.3M 4.86%
Mar 23, 2023 5.76 5.81
6.1
5.61
5.7M -0.35%
Mar 22, 2023 5.78 6.07
6.17
5.77
4.7M -3.99%
Mar 21, 2023 6.02 6.02
6.36
5.92
4.3M 0.67%
Mar 20, 2023 5.98 5.8
6
5.7
3.3M 0.50%
Mar 17, 2023 5.95 5.95
6
5.76
14.2M -0.34%
Mar 16, 2023 5.97 5.83
6.05
5.68
5.3M 1.19%
Mar 15, 2023 5.9 6.2
6.39
5.85
7.5M -5.9%
Mar 14, 2023 6.27 6.88
7.05
6.22
6.5M -8.47%
Mar 13, 2023 6.85 6.46
7.22
6.41
7.9M 5.06%
Mar 10, 2023 6.52 6.54
6.73
6.25
7.1M -0.76%
Mar 9, 2023 6.57 6.86
6.95
6.55
3.8M -4.64%
Mar 8, 2023 6.89 6.93
6.95
6.76
5.3M -1.15%
Mar 7, 2023 6.97 7.27
7.27
6.93
4.6M -4.39%
Mar 6, 2023 7.29 7.48
7.7
7.16
7.2M -5.2%
Mar 3, 2023 7.69 6.94
7.92
6.79
11.0M 0%